Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
CVM very nice indeed! Man so many out there to pick! Getting dizzy here!
I like PMBS here! Nice chart, nice S/S too!
Will do. CVM looking real nice here
APPA - Time to re-visit this baby! Reminder: A.P. Pharma Closes Underwritten Offering of Common Stock ref. http://finance.yahoo.com/news/p-pharma-closes-underwritten-offering-140700725.html
Upcoming CATAlYST. Refiling NDA for Sustol™ (formerly known as APF530) targeted for the end of the first quarter 2014...
CVM still looking good
Excellent SmurfVA! INSV looking good so far this am
Good stuff here retiremeearly! Will look into it!
2014 FDA ADCOM Meeting Schedule
http://www.fda.gov/AdvisoryCommittees/Calendar/ucm153468.htm
SCTPF: great potential stem cell company. I just started a position in it last month. Good long term hold.
CRMD $1.46 L2 thin
Looking for 2.30-2.50 FV
Just started shipping product in EU
US market next
http://stockcharts.com/h-sc/ui?s=crmd
Thanks Angel - nice to see you :)
BM , RM .
Good call on Pharma stock. CVM and LJPC :)))
Nice one jellyfish. Check out the price action on CVM yesterday too.
SVFC - closed above the 50 day (MA) The whole stem cell sector is heating up and 2014 looks like it could be a very profitable year. Lots of major catalysts ahead including 5 pending international patents, license agreements, and major financing.
Yes, still watching this one very closely. Took a position in LJPC today, agree with $heff on this one, should be a good one to hold for the next few months...
IGXT - (February 3, 2014)- Still far away...watching this.. I like to see this get closer to $.60 before starting a position IMO.
Thank you for stopping in, I'm looking forward to getting this board active for 2014!
Thought to stop in with a few choices-BONE (.51) /MELA (.65)-NVLX (.10) and SBFM (.17)
GLTA
Investor 100
SCTPF
This stock looks to be a good longterm hold with excellent prospects. They are developing a cancer immunotherapy that targets CD47. This is one of the newest approaches to treating cancer. Stanford is currently leading the pack in doing the research. (SCTPF is about one year behind.) Once Stanford's early studies are completed in 2014, you'll likely see biotechs quickly getting on the CD47 bandwagon, and CD47 stocks should then take off.
The other very nice thing about this stock is that they just did a large round of financing through a private placement. The leader of the pack in this financing? Baker Brothers. So you know this stock is legit, despite being OTC.
The potential here for incredible longterm gains is pretty good and I think there's a good shot at a double in 2014. (If CD47 takes off, this stock will go well past doubling given its low market cap.) The stock can be fairly illiquid (and shares are difficult to purchase even if you are sitting on the ask) so it is probably a better longterm hold than it is a trading stock. But given the low market cap here, I think it's worth it.
These threes all indeed good/solid flippers. Easy profit imo!
I've flipped IGXT, IMUC and MSTX over the past week, all could go even higher in January.....
IMUC still good imo. Watching IGXT now... creeping up for next run imo...
Indeed indeed! Still watching IMUC now. Last week's run was GOOD! IGXT on watch here also creeping up soon to $1 plus IMO....
IMUC - looking good.....
can someone share information on FPMI's upcoming phase 2 trial? I'm having a hard time finding it on their website.
Nice call Smurf - IMUC looks good!
Thanks TK... anything in pipeline? I need to do little more DD here.
ISCO - stem cell, current Market Cap is around 30Mil. Very undervalued, compare to other stem cell companies ACTC, STEM, GERN, ...
TK
INSV looking good this am, upcoming catalyst for them. P3 data due before EOY
I got it off someone on the IGXT board's post. It has been clarified by retiremeearly that there is only one catalyst. I wonder what INSV's potential is hmm. No significant run up so..
It's for Feb, only 1 catalyst
The migraine drug FDA approval date of (February 3, 2014)- I can only see this Catalyst.. where are you seeing Jan?
INSV - on radar here
InSite Vision expects that top-line data from the BromSite confirmatory Phase 3 clinical trial will be available before the end of 2013.
http://phx.corporate-ir.net/phoenix.zhtml?c=86061&p=irol-newsArticle&ID=1874101&highlight=
Sounds good to be Buddy, thank you, make some $$$$$ together!
Hey Wrinks, good to see you again my friend! Hoping we can do some good things here on this board. IGXT and MSTX both look nice!
Hi SoftDaddy and Retiremeearly, hope you two fellas are doing well. Wake this puppy up and make some dough ray me/$$$$$! Board marked last time around, not able to do it again, or I would fo sure!!! IGXT looks like a goodie....I did not buy that one, but did buy MSTX recently at .41 to poke and hope with, as far as sub buck bios go.
Wrinks
$heff just posted this as well IGXT I'll get a starter
Limit Order Placed
Thank you! Your order to Buy 3000 Shares of IGXT (INTELGENX TECHNOLOGIES CORPORATION) at Limit Price of $0.515 has been submitted. Duration of this order is Today (Good until 4:00 PM ET).
The theme of this board is to discuss all Biotech (and Pharma) plays with upcoming catalysts (ADCOM/PDUFA/ Trial Data etc.), currently trading under $1 into one location. This picks here will include any Nasdaq/OTC/BB's.
Can not think of a better guy to do that...get Wrinks involved...people chase his butt around in the hope to pick up his scraps
Hey SBD! Hoping to revitalize the board with some sub $1 catalyst plays.
Seems to be getting some attention on other boards as well
IGXT
Wrinkles you stop by the best places
I like IGXT here - nice price action since the offering has closed.
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |